Evidence map›Paper›PMID 40689756›Full record

ArticleAntimicrobial agents and chemotherapy2025

The addition of amoxicillin improves the efficacy of the imipenem-avibactam combination against

Vincent Le Moigne, Maria Bitar, Michel Arthur, Jean-Luc Mainardi, Jean-Louis Herrmann

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vincent Le Moigne *Université Paris-Saclay, UVSQ, INSERM, Infection et Inflammation, Montigny-le-Bretonneux, France.ORCID 0000-0003-2012-1750
Maria Bitar *INSERM ERL 1336, UMRS 8228, Sorbonne Université-ENS-PSL-CNRS, Paris, France.
Michel ArthurINSERM ERL 1336, UMRS 8228, Sorbonne Université-ENS-PSL-CNRS, Paris, France.ORCID 0000-0003-1007-636X
Jean-Luc MainardiINSERM ERL 1336, UMRS 8228, Sorbonne Université-ENS-PSL-CNRS, Paris, France.ORCID 0000-0002-4159-0129
Jean-Louis HerrmannUniversité Paris-Saclay, UVSQ, INSERM, Infection et Inflammation, Montigny-le-Bretonneux, France.ORCID 0000-0003-2347-6418

Funding

Association Gregory Lemarchal RF20220503036Association Vaincre la Mucoviscidose RF20220503036
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmoxicillinAnti-Bacterial AgentsAzabicyclo CompoundsImipenemMycobacterium abscessusMycobacterium Infections, NontuberculousAnimalsDisease Models, AnimalDrug CombinationsDrug Therapy, CombinationKidneyLungMiceMicrobial Sensitivity TestsAmoxicillinAnti-Bacterial AgentsavibactamAzabicyclo CompoundsDrug CombinationsImipenembeta-lactamscystic fibrosisDBOMycobacterium abscessus

Identifiers

PMID40689756
PMCPMC12327000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.